|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-1-31
|
|
pubmed:abstractText |
Bullous pemphigoid is the most common autoimmune blistering skin disease of the elderly. Because elderly people have low tolerance for standard regimens of oral corticosteroids, we studied whether highly potent topical corticosteroids could decrease mortality while controlling disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BedaneChristopheC,
pubmed-author:BenichouJacquesJ,
pubmed-author:BernardPhilippeP,
pubmed-author:Bullous Diseases French Study Group,
pubmed-author:D'IncanMichelM,
pubmed-author:DelaporteEmmanuelE,
pubmed-author:DrenoBrigitteB,
pubmed-author:JolyPascalP,
pubmed-author:PicardCatherineC,
pubmed-author:PlantinPatriceP,
pubmed-author:RoujeauJean-ClaudeJC,
pubmed-author:VaillantLoicL,
pubmed-author:YoungPaulP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
31
|
|
pubmed:volume |
346
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
321-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11821508-Administration, Oral,
pubmed-meshheading:11821508-Administration, Topical,
pubmed-meshheading:11821508-Aged,
pubmed-meshheading:11821508-Aged, 80 and over,
pubmed-meshheading:11821508-Clobetasol,
pubmed-meshheading:11821508-Glucocorticoids,
pubmed-meshheading:11821508-Hospitalization,
pubmed-meshheading:11821508-Humans,
pubmed-meshheading:11821508-Length of Stay,
pubmed-meshheading:11821508-Ointments,
pubmed-meshheading:11821508-Pemphigoid, Bullous,
pubmed-meshheading:11821508-Prednisone,
pubmed-meshheading:11821508-Proportional Hazards Models,
pubmed-meshheading:11821508-Recurrence,
pubmed-meshheading:11821508-Survival Rate
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
|
|
pubmed:affiliation |
Department of Dermatology and Biostatistics, INSERM Unite 519, University of Rouen, Rouen, France. pascal.joly@chu-rouen.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
